Home » Newsletters » BioWorld Asia

BioWorld Asia

Jan. 7, 2004

View Archived Issues

Celltech Details Phase III Trial Plans For CDP870 In Crohn's

A Phase III program in Crohn's disease is under way to evaluate a compound being developed by Celltech Group plc. (BioWorld International) Read More

Innogenetics Forms Hepatitis C Union With Roche Diagnostics

Researchers Find Gene Similar To BRCA1 In Nematode Worm

SkyePharma Disputing GSK's Royalty Payment For Paxil CR

Xenova Gets US$1.5M From Sale Of KSB's Monoclonal Business

Eirx Seeks To Raise £1M Via Initial Public Offering On AIM

U.S. Navy To Evaluate Inovio's DNA Vaccine Delivery System

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...